Your weight loss journey
Average progress over time, across all newer medications.
Less hunger and food noise — your body is adjusting. Scale may not move yet.
For a 240 lb person, roughly 5–7 lbs.
Well into the active weight loss phase. Dose is ramping up.
Clothes fit differently. Health markers improving. For a 240 lb person, roughly 24–34 lbs.
Weight loss slows as your body reaches a new equilibrium.
Semaglutide injection ~15%, semaglutide pill ~17%, tirzepatide ~21%.
Ranges across newer drugs. Individual results vary by drug, dose, and person.
Results by drug
How quickly you lose depends on which drug you take. Average trial results at each milestone.
About 57% of people lost 20%+
With full adherence
About 37% of people lost 20%+
Daily pill, no food timing restrictions
Averages from clinical trials at highest approved dose. For a 240 lb person. Not everyone achieves these results.
Want your personal numbers? Try the calculator →
What the first weeks actually feel like
Week 1–2
Less hunger between meals. Food noise quiets. Some people feel nausea — usually mild and short-lived.
Week 3–4
Portions naturally shrink. Scale starts moving. You may eat half of what you used to without trying.
Month 2–3
Dose increases bring faster loss. Nausea usually settles. Clothes feel looser. Other people may start to notice.
Want the full week-by-week guide? Read: Your first weeks on medication →
After peak results — what happens next?
Weight loss typically plateaus around months 12–15. This does not mean the drug stopped working. It means your body has reached a new equilibrium. The drug is still actively preventing regain.
If you continue
- →Weight loss maintained long-term in trials
- →Health improvements (blood pressure, blood sugar) preserved
- →Ongoing cost — explore savings programs and insurance
If you stop
- →About 2 in 3 people regain most weight within 1 year (semaglutide)
- →Around 14% body weight regain within a year (tirzepatide)
- →Hunger signals return — this is biology, not willpower
Current evidence suggests most people need to continue medication long-term. Research on lower maintenance doses is ongoing. This is a decision to revisit regularly with your doctor — not a one-time choice.
Common questions
See results by medication
Next step most people take
Backed by evidence · Every claim linked to its source
Last reviewed: April 2026